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There is abundant  experimental  evidence that  both the M  protein and  the 
capsular  gel  of  Group  A  streptococci  play  significant  roles  in  pathogenicity 
(1-7). That they enhance virulence by interfering  with surface phagocytosis is 
indicated by the observations described in the preceding paper (8). 
Despite the general agreement  that both the capsules and the M  protein of 
Group A  streptococci are antiphagocytic  (9,  10),  their  precise relationship  to 
virulence  has  remained  obscure.  Numerous  strains  have  been  described,  for 
example, which appear to produce abundant amounts of M  protein and yet are 
relatively avirulent for mice (1,  11-14).  Others possessing large capsules have, 
likewise,  been found  to  be lacking  in virulence  (3,  15),  as  illustrated  by the 
glossy variant of the $23 strain referred to in the accompanying paper (8). In- 
deed, it has been shown that  streptococci which produce both capsules and  M 
substance also may lack pathogenicity for mice. The T14 strain,  used in  this 
and the previous study, is just such an organism (8). 
In the case of pneumococcal and Friediander's  bacillus infections,  the situa- 
tion  is less complex  (16),  inasmuch  as  these organisms  are protected  against 
leucocytes  by  a  single  antiphagocytic  factor  (i.e.,  a  carbohydrate  capsule) 
(9,  17,  18). As has been emphasized  elsewhere, however,  the quantitative  as- 
pects of capsule formation have a direct bearing upon the virulence of organisms 
such as Type III Pneumococcus (19, 20). This fact, taken in conjunction with 
the knowledge that a double antiphagocytic mechanism is involved in Group A 
streptococcal infections,  has prompted us to restudy the quantitative and com- 
bined effects of the M  protein and the hyaluronate capsule upon phagocytosis. 
The results appear to clarify the relationship of both factors to virulence. 
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United States Public Health Service (E-1670). 
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Materials and Methods 
Streptococcal Cultures.--The  four strains of Group A streptococci studied were the same as 
those used in the preceding experiments (8). They included: (a) the matt (M) and glossy (G) 
variants  of Strain  $23,  both of which form large capsules,  but  only one of which  (matt) 
produces detectable amounts of M protein (Table I), and (b) the matt virulent Strain T14/'46 
and its avirulent variant, T14 (Table II), both of which form capsules smaller than those of 
the $23  strains, and one of which (T14)  produces less M  antigen than the other (T14/46). 
The relative virulences of the four strains, when injected intraperitoneally in both mice and 
rats, vary over a relatively wide range and rank in the following order: $23M (most virulent), 
T14/46, $23G,  and T14 (see Table I  of previous paper (8)).  The methods used in culturing 
these strains  and  in studying their capsules,  their production of M  protein and  their sus- 
ceptibility to phagocytosis have already been described  (8). The phagocytic tests were per- 
formed with rat leucocytes. 
Removal of M  Protein.--Salt-free  crystalline trypsin  (lyophilized 1)  dissolved in Locke's 
solution at a concentration of 10 mg. per ml. was used in all experiments to remove M pro- 
rein. As has been shown by Lancefield (21), this enzyme may be employed to destroy the M 
antigen without affecting the viability of streptococcal cells.  Organisms from 2 to 2~ hour 
cultures, packed to a volume of approximately 0.4 ml. by centrifugation in the cold at 1500 
g for 25 minutes, were suspended in 1 ml. of Locke's solution, to which was added 0.1 ml. of 
trypsin solution. As soon as the mixture had been thoroughly mixed and incubated for 12 
minutes at 37°C.,  the organisms were washed with 5 ml. of Locke's solution to remove most 
of the trypsin and were centrifuged for 25 minutes at 1500 g in the cold. The packed strepto- 
coccal cells were then used immediately for phagocytic studies as  previously described  (8). 
Quadruplicate bacterial suspensions  were prepared in each experiment. Suspension 1 served 
as a  control, the organisms being incubated for 12 minutes in the absence of trypsin,  and 
suspension  2 was incubated in the presence of trypsin. Both were used for phagocytic tests. 
Suspensions  3 and 4 were incubated in the presence and absence of trypsin, respectively, and 
were later tested with Type 14 antiserum (22) to determine whether or not all of the M anti- 
gen had been destroyed by the trypsin.  No residual M  protein was detected in any of the 
trypsin-treated suspensions. 
Destruction of Capsular Gal.--Similar experiments were performed with streptococci pre- 
treated  with hyaluronidase  to  remove the capsular  gel  (5,  7).  Lyophilized hyaluronidase  2 
obtained from bovine testes was dissolved in Locke's solution in a  concentration of 10 tur- 
bidity reducing units  (TRU) per ml. A volume of 0.1 ml. (1 TRU) was added to 1.4 ml. of 
the bacterial suspension,  prepared as described above, and the resulting mixture was incubated 
~t 37°C. for 12 minutes. The enzyme-treated organisms were then lightly centrifuged at 400 g 
for 5 minutes, separated from the supematant,  and mixed in the usual way with leucocytes 
(8). To prevent the reformation of capsules (3, 5, 7) during the 30 minute period of incubation 
required for the phagocytic tests, 2 to 3 TRU of hyaluronldase in 0.02 to 0.03 ml. of Locke's 
solution were added to each mixture of leucocytes and enzyme-treated streptococci prior to 
the start of incubation. 
Simultaneous elimination of M  protein and capsular gel was accomplished by combining 
both of the above methods in a single procedure.  When brought  together, the two enzymes 
retained  their activity during the period of incubation. 
EXPERIMENTAL  RESULTS 
Effects  of Enzymes  upon  Streptococcal  Cells.--The  incubation  with  trypsin 
invariably eliminated all detectable M  antigen in the suspensions of the M-con- 
1 Worthington Biochemical Corporation, Freehold, New Jersey. 
2 Worthington Biochemical Corporation, Freehold, New Jersey. ~. ]. FOLEY AND  W.  BARRY  WOOD~ JR.  619 
taining Strains $23M, T14/46, and T14. Strain $23G, as already stated, pro- 
duces no detectable M protein even in the absence of trypsin. Capsular studies 
performed with India ink (23) showed that the trypsin did not visibly alter the 
capsules of any of the four strains (see Tables I  and II, and Fig. 1). 
The  treatment with hyaluronidase, on the other hand, had no significant 
effect upon the M protein but markedly reduced the size of all of the capsules 
(Tables I and II, and Fig. 1). When the concentration of enzyme was increased, 
or the period of incubation was prolonged, the organisms became completely 
denuded  (Fig.  1)  and spontaneous agglutination rapidly ensued.  Since such 
unstable suspensions could not be used in the phagocytic tests (12),  the hyal- 
uronidase treatment  was  regularly stopped  at  the  point  at  which  a  barely 
detectable amount of gel still remained on the surfaces of the organisms (Fig. 
1).  Even in this state,  the  treated streptococcal cells  were often difficult to 
resuspend unless care was taken to avoid packing them during centrifugation 
(see Materials and Methods). 
As expected, the combined treatment with trypsin and hyaluronidase removed 
both the capsule and the M protein (Tables I and II). 
Effect of Enzymes upon Leucocytes.--To determine whether the trypsin, in 
the  concentrations used,  influenced phagocytosis by acting upon  the  leuco- 
cytes, phagocytic tests in both the presence and absence of trypsin were per- 
formed with the M-deficient Strain $23G.  This strain was chosen for study 
because it lacks the protein antiphagocytic M substance upon which trypsin is 
known to act (21). Since the trypsin had no significant effect upon the results of 
the phagocytic tests  (see  Table  I),  it  was  evident that  the  enzyme neither 
stimulated nor depressed  the  phagocytic activity of  the  leucocytes. Similar 
experiments were done with hyaluronldase, using Type III pneumococci (19), 
the capsules of which are resistant to the action of the enzyme. The hyaluroni- 
dase was present in twice the concentration of that in the streptococcal phago- 
cytic tests. That it likewise did not affect the leucocytes was indicated by the 
fact that the amount of phagocytosis which occurred was uninfluenced by its 
presence? From these findings it may be concluded that neither of the enzymes, 
in the amounts used, acted directly upon the leucocytes. The effects that they 
did have in promoting phagocytosis in the experiments described below must, 
therefore, be attributed to their action upon the antiphagocytic components of 
the streptococcal cells. 
Susceptibility of Enzyme-Treated Streptococci to Phagocytosis.--The results of 
the phagocytic tests with enzyme-treated organisms are summarized in Tables 
I  and II.  4 The data reveal the following points of interest: 
8  Hyalurouidase  has been reported by Ludany et aL (24) to stimulate the phagocytosis  of 
staphylococci  and typhoid bacilli in the presence of serum, but the conditions  of their experi- 
ments were quite different from those of the present study. 
4 The statistical analyses included in Tables I  and II were made with the assistance of 
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1. The phagocytic tests performed on filter paper (surface phagocytosis) are 
considerably more sensitive than those done with glass slides or roller tubes in 
detecting  the  changes  in  phagocytability  resulting  from  the  actions  of  the 
trypsin and the hyaluronidase. In the case of Strain $23M, for example, neither 
TABLE I 
The Effect of Trypsin and tIyaluronidase  on Phagocytosis of Strains $23 Matt and $23 Glossy 
Stra/n  $23  matt 
Treatment 
None 
rrypsin 
kIyaluronidase 
grypsin plus hyaluronidase 
State of 
capsule* 
+++ 
+++ 
4- 
-4- 
State of M 
protein* 
+++ 
+++ 
Phagocytosls:~,  § 
Filter paper 
pet Ce~ 
3 
49 
41 
64 
Glass slide 
t~¢r ten# 
1 
1 
4 
29 
Roller tube 
1 
3 
8 
4O 
Strain S23 glossy 
None 
Trypsin 
Hyaluronidase 
Trypsin plus hyaluronidase 
+++ 
+++ 
4. 
4- 
b 
28 
24 
74 
68 
1 
1 
25 
43 
0 
3 
58 
57 
* Arbitrarily  designated in terms of +  and -- symbols  (8). In case of capsule, number of 
plus signs refers to approximate  size of capsular envelope, and 4- sign indicates removal of 
practically  all of the capsule by hyaluronidase  (see Fig. 1). The number of plus signs in the 
M protein  column refers to the relative amount of the antigen  demonstrable  by precipitin 
test, and a negative sign denotes that none is detectable. 
Percentage  of rat polymorphonuclear  leucocytes containing  one or more streptococcal 
units  (8). 
§ Standard  deviation  (a measurement  of the variability  of individual  experiments  (8)) 
is for each experiment, reading down the 3 columns in order,  as follows: 1.8, 5.4, 2.8, 0.85, 
3.5, 1.1, 3.6, 6.1; 0.6, 1.0, 1.9, 8.5, 0.73, 0.71, 16.0, 5.6; 0, 0, 4.1, 9.0, 0, 0.71, 7.0, 0. 
the effect of the  trypsin nor that of the hyaluronidase is dearly indicated  by 
the  results  of the  phagocytic tests  on glass,  whereas  the  effects  of both  are 
strikingly demonstrated  by the  tests  on filter paper.  The same is true also of 
Strain  T14/46.  Only when  the  antiphagocytic  powers  of  the  organisms  are 
greatly reduced, does an appreciable amount of phagocytosis occur on glass, in M.  J.  ~'OLEY AND  W.  BARRY WOOD, JR.  621 
which case it is consistently somewhat greater in the roller tubes than in the 
"stationary" preparations on the glass slides. ~ 
2. Removal of either the capsular gel or the M  protein greatly increases the 
susceptibility of both the virulent strains, $23M and T14/46, to surface phago- 
TABLE II 
The  Effect  of Trypsin  and  Hyaluronidase  on  Phagocytosis of 
Strains  T14/46  (Matt  Virulent)  and  T14  (Matt  Avirulent) 
Strain T14/46  (matt virulent) 
Treatment 
None 
trypsin 
[-Iyaluronidase 
rrypsin plus hyaluronidase 
State of 
capsule* 
+-b 
q-+ 
-4- 
4- 
State of M 
protein* 
+++ 
+++ 
Strain T14  natt avirulent 
Phagocytosls*, 
Filter paper  Glass  slide 
per ce~t  per ~ent 
10  1 
52  0 
33  5 
61  22 
RoUertube 
2 
1 
8 
48 
None 
Trypsin 
Hyaluronldase 
Trypsin plus hyaluronidase 
++ 
q-+ 
q- 
++ 
++ 
49 
63 
52 
64 
2 
2 
36 
49 
2 
2 
50 
49 
* As in Table I. 
:~ Standard deviation, recorded as in Table I, is for each experiment as follows: 0.53,  1.3, 
1.3, 6.3,  8.9,  0.71,  2.1,  0.71; 0,62,  0.57,  2.1,  8.9,  0.55,  0,  6.4,  3.5;  0.60,  0.99,  4.2,  8.1, 1.0, 
0.71, 3.5, 3.6. 
cytosis. Elimination of the two antiphagocytic factors simultaneously, by com- 
bined enzyme treatment, makes both strains still more susceptible to phago- 
cytosis. Indeed, under  the  latter  conditions,  their susceptibility becomes  so 
5 It is well known that the ingestion of easily phagocyted bacteria occurs more readily in 
a moving roller tube than on a stationary glass slide, owing to the greater number of contacts 
between  leucocytes and  bacteria  resulting  from  the  constant  agitation  of the  roller tube 
mixture (25). It is often not appreciated, however, that no such difference is demonstrable in 
the case of encapsulated bacteria which are capable of resisting phagocytosis. This latter fact 
is well illustrated by the data in Tables I  and II, relating to all of the untreated organisms. 622  PATHOGENICITY  OF  GROUP  A  STREPTOCOCCI.  II 
great  that  they are  readily phagocyted on glass.  These observations dearly 
indicate that the antiphagocytic properties, and thus the virulence of Strains 
$23M and T14/46 depend upon the presence of both the capsular gel and the 
M  protein. 
3.  As would be expected from the fact that the less virulent glossy strain, 
$23G, produces no detectable M substance, it (a) is not as resistant to surface 
phagocytosis (and thus not as virulent) as either $23M or T14/46,  and (b) is 
rendered more susceptible  to phagocytosis only by hyaluronidase. When its 
capsule is removed by the latter enzyme, the organism becomes so unresistant 
to phagocytosis that it is easily ingested even on glass. 6 What ability it possesses 
to protect itself against leucocytes appears,  therefore, to be due primarily, if 
not solely, to its relatively large capsule. 
4.  A still different situation is exemplified by the least virulent strain, T14. 
Though it possesses  both capsule and M  protein,  this strain has a  definitely 
smaller capsule than either of the $23  strains and produces less M  substance 
than its more virulent relative, T14/46 (8). That its smaller complement of M 
protein is functionally deficient is indicated by the facts: (a) that its destruction 
by trypsin causes little increase in phagocytability, and (b)  that it possesses 
very little capacity to protect the organism against phagocytosis even on glass 
slides,  once the capsule has been removed with hyaluronidase. The relatively 
small hyaluronic acid capsule, on the other hand, is somewhat more effective 
as an antiphagocytic factor, since it at least protects the organism from being 
phagocyted on glass. 
DISCUSSION 
These findings further substantiate the now generally accepted hypothesis 
(1-7, 9,  10, 12,  15) that both the M  protein and the hyaluronic acid capsule 
are  important virulence factors of  Group  A  streptococci.  In  addition,  they 
suggest  a  logical  explanation  for  the  quantitative  differences  in  virulence 
exhibited by the four streptococcal strains which were subjected to analysis. 
Evidence that the virulence of each strain, as determined by intraperitoneal 
injection in mice and rats, is directly related to susceptibility to surface phago- 
cytosis has been presented in the preceding paper (8). The results of the present 
study indicate that the phagocytability of each strain is dependent upon the 
combined antiphagocytic effects of the M  protein and the capsular gel.  The 
s Similarly the pathogenicity  of Group C streptococci, which produce large hyaluronate 
capsules but no detectable M substance, is markedly affected  by treatment with hyaluroni- 
dase (3, 26). 
The relative irregularity of the results obtained with the hyaluronidase-treated $23G 
strain on glass (note standard deviation,  Table I) was due to the difficulty  involved  in remov- 
ing exactly the fight amount of the capsular gel with the enzyme (see Methods). M.  ~'.  FOLEY  AND  W.  BARRY  WOOD,  JR.  623 
quantitative aspects of the combined effects have been shown to be of definite 
significance. 
The data obtained from the phagocytic tests summarized in Tables I  and 
II suggest the following conclusions: 
1. The most vinflent strain of the four studied, $23M (matt), owes its high 
degree of pathogenicity to the fact that it produces a  relatively large capsule 
and a full complement of M protein. Both factors are strongly anfiphagocyfic. 
2. The second most virulent strain, T14/46, also produces both factors, but 
its capsule is definitely smaller than that of $23M,  and  the combined anti- 
phagocytic effects of its capsule and its M  protein are not as pronounced as 
those of the more virulent $23M strain. 
3. The third most virulent strain, $23G (glossy), produces no M  substance, 
its pathogenicity depending primarily, if not entirely, upon the anfiphagocytic 
effect of its large hyaluronic acid capsule. 
4. The least virulent strain, T14, although its produces both a  capsule and 
M protein, is deficient (as compared to $23M) in both factors, and particularly 
in the latter. 
The reason for the relative lack of antiphagocytic effectiveness of the  M 
protein in the T14 cell is not entirely clear. Besides being deficient in quantity, 
its location in the cell may be of importance (7,  15, 26).  Since it is present in 
lesser amount than in T14/46, it may conceivably fail to extend far enough into 
the  capsule to exert a  maximum effect upon phagocytosis. Although the M 
protein is known to be concentrated primarily in the cell wall (27), it must be 
assumed to act either directly or indirectly upon the capsular surface, in order 
to influence the phagocytability of the encapsulated organism (7). It is evident, 
however, that more must be learned of the spatial relationship of the M  pro- 
tein to the hyaluronic acid capsule,  7 before the ineffectiveness of the T14 M 
substance as an antiphagocytic factor can be adequately explained. The one 
point that appears to be clearly established is that the lack of virulence of the 
T14 strain, for both mice and rats, is directly related to its inability to resist 
phagocytosis. 
A number of attempts have been made to assess  the relative importance of 
the hyaluronic capsule as a  virulence factor in comparison to the M  protein 
(3,  5-7). Although treatment of a  number of strains of Group A streptococci 
with hyaluronidase has resulted in an increase of phagocytosis and destruction 
of the organisms in vitro (3,  5,  7),  the results of analogous experiments per- 
formed in ~ivo have revealed only a  slight effect from the hyaluronidase (3, 5, 
29). The latter finding has led a number of workers to conclude that the hyal- 
The kind of information  which may be needed is suggested by the studies of Tomcsik 
relating to the spatial relationships  of the protein and carbohydrate components  which form 
the capsules of certain Gram-positive  bacilli (28). 624  PATHOGENICITY  OF GROUP  A  STREPTOCOCCI. II 
uronic  acid  capsule  contributes  relatively little  to  the pathogenicity  of  the 
invading  organisms  (2, 3,  10). Such in v/vo experiments must be interpreted 
with caution, however, since the actively metabolizing streptococcal cells will 
quickly form capsules  as soon as  the  concentration  of hyaluronidase  in  the 
surrounding medium falls below the level necessary for rapid depolymerization 
of the polysaccharide (3, 5,  7,  29).  There is no assurance that  the necessary 
level of enzymatic activity can be constantly maintained in the tissues by inter- 
mittent injections of the enzyme (5, 7). The protective effect achieved by the 
hyaluronidase treatment may, therefore,  be a relatively poor indicator of the 
part played by the capsular gel. Indeed, the in v/tro data reported in the present 
study clearly indicate  that  the hyaluronic  capsules  of Group A  streptococci 
greatly enhance their capacity to resist surface phagocytosis. Since the defense 
of the host in the early stages of streptococcal infections  has been shown to 
depend primarily upon surface phagocytosis (8), it must be concluded that the 
capsules play a significant role in pathogenicity. Manifestly both the M protein 
and  the  capsular  gel  are of great  importance.  When  their  combined  actions 
are quantitatively  measured by properly designed  tests for phagocytosis, many 
of the discrepancies,  which have recently been emphasized  (10, 12, 26) regarding 
their individual roles in streptococcal virulence,  appear to be explainable. 
The double antiphagocytic effect of the M  protein and the hyaluronic acid 
is strikingly similar  to that of the "double capsule" of Type III Pneumococcus 
(19, 20). Virulent strains of the latter organism produce, in addition to the usual 
polysaccharide envelope,  an outer "slime layer," which is present only during 
the  logarithmic  phase  of  growth,  and  which  inhibits  surface  phagocytosis. 
When, during the later stages of growth, the slime layer diffuses from the Type 
III  cell, leaving  behind  only the capsule  proper,  the organism  becomes sus- 
ceptible to surface phagocytosis, though it is still able to resist phagocytosis on 
glass.  In  this  state  it  behaves like  the  $23M  streptococcus which has  been 
deprived either of its capsule or its M protein (see Table I). Thus both Type 
III pneumococci and Group A streptococci may exhibit three different degrees 
of susceptibility to phagocytosis. When Type III pneumococcus possesses  its 
slime layer as well as its capsule  proper, it is highly resistant both to surface 
phagocytosis and to phagocytosis on glass (19). The same is true of Group A 
streptococci, which produce large capsules and a full complement of M protein 
(8). When the streptococcus has lost either its M protein or its capsule, and the 
slime layer has diffused from the Type III capsule,  both organisms  are suscep- 
tible to surface phagocytosis but continue to be resistant on glass.  Finally, if 
reduced to their  "rough"  forms,  in which they possess  neither of their anti- 
phagocytic factors,  both  species  are  readily ingested by leucocytes even on 
glass. It is evident, therefore,  that resistance  to phagocytosis in the absence of 
opsonins  is a relative matter and cannot be satisfactorily measured by phago- 
cytic tests performed on glass slides or in glass roller tubes. Only when pneumo- 
cocci and Group A streptococci are subjected to phagocytic tests which simulate M.  J.  ]FOLEY AND W.  BARRY WOOD, JR.  625 
conditions in vivo, is there a  meaningful correlation between phagocytability 
and virulence,  s 
One other similarity between Type III pneumococcus and Group A strepto- 
cocci is noteworthy. It concerns their ability to produce suppuration.  Unlike 
practically all other types of pneumococci, virulent strains  of Type III  not 
infrequently cause lung abscesses (30). Their occurrence can be readily demon- 
strated as a  sequel to experimental Type III pneumonia in rats (20). Similar 
lesions occur following experimental streptococcal pneumonia  (31),  and sup- 
puration  is  frequently  observed  in  other  experimental  (32)  and  naturally 
occurring streptococcal infections (33).  As  reported elsewhere (20),  the  sup- 
purative lesions produced by Type III pneumococcus are apparently caused 
by the extraordinarily high concentration of viable organisms which accumulate 
in the tissues. The ability of the Type HI organism to reach such high popula- 
tion densities in the tissues is due to its ability to resist surface phagocytosis 
and thus to continue to multiply in situ for some time after the usual accumula- 
tion of tissue phagocytes. Other types of pneumococci, such as Type I, though 
relatively virulent, produce no demonstrable outer slime layer and accordingly 
are susceptible to surface phagocytosis (17). These organisms ordinarily reach 
a maximum population density in the tissues which is  about a hundred times 
less than that reached by Pneumococcus  III (20, 34). When, however, they are 
inoculated  in  sufficient  numbers  to  produce  a  maximum  tissue  population 
comparable to that  of Type III infections, they too cause suppuration  (20). 
Since the most virulent strains of Group A streptococci are capable of resisting 
surface phagocytosis and thus of reaching relatively high population densities 
in  the  tissues  (31),  it  would appear  that  the  basic  mechanisms  involved in 
their suppurative capacities are similar to those which operate in lesions caused 
by Pneumococc~ Type III. 
SU'M~ARY 
A quantitative study of the combined antiphagocytic effects of the M protein 
and the hyaluronic acid capsules of four strains of Group A streptococci revealed 
the following facts relating to their intraperitoneal virulence in mice and rats: 
1. The most virulent strain, $23M (matt), produced both a large hyaluronic 
acid capsule and a full complement of M protein, the combined effects of which 
rendered the organism highly resistant to surface phagocytosis. 
s These statements should not be construed as indicating that all phagocytic tests per- 
formed on glass are valueless for estimating phagocytability, for manifestly they provide a 
rough measure of the ability of test organisms to resist ingestion. However, they do not give 
the leucocytes  the same advantages that they have in tissues, and, therefore, the organisms 
appear to be more resistant to phagocytosis  than they really are in t~vo. Accordingly,  it is not 
surprising that the results of tests on glass do not correlate as well with virulence as do the 
results of tests designed to measure surface phagocytosis. 626  PATHOGENICITY  OF GROUP  A  STREPTOCOCCI.  II 
2.  The slightly less virulent strain,  T14/46  (matt virulent)  was somewhat 
more susceptible to surface phagocytosis owing to the fact that its smaller cap- 
sule was less antiphagocytic than that of the $23M organism. 
3. The glossy variant of the $23 strain ($23G), which ranked third in viru- 
lence, was still more susceptible to surface phagocytosis because of its lack of 
detectable M substance. Its large hyaluronic acid capsule, however, was capable 
of protecting it against phagocytosis on glass. 
4. The least virulent strain, T14 (matt avirulent), was the most susceptible 
of all  to phagocytosis. Though it possessed both  M  substance and  capsule, 
which together prevented its phagocytosis on glass, each of them was shown to 
be quantitatively and functionally deficient as compared to Strain $23M. 
The differences in phagocytability, which appear  to be directly related to 
the pathogenicity of the organisms, could be adequately demonstrated in vitro 
only by  phagocytic  tests  designed  to  measure  surface  phagocytosis  in  the 
absence of opsonins. This fact is in keeping with the observation, previously 
reported,  that surface phagocytosis plays a  critical role in the defense of the 
host, particularly during the earliest stages of experimental streptococcal infec- 
tions. Its possible relation to suppuration during the later stages of infection is 
also discussed. 
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EXPLANATION OF PLATE 40 
FIG. 1. India ink preparations of strain $23 matt showing effects of treatment with 
trypsin and with hyaluronidase.  Organisms from 21/~ hour cultures.  ×  1,100. 
a. Untreated. 
b. Treated with trypsin. 
c. Treated sparingly  with hyaluronidase.  Note that capsules have not been com- 
pletely removed. 
d. Treated with hyaluronidase plus trypsin. 
e. Overtreated with hyaluronidase.  Such  completely  denuded organisms  undergo 
spontaneous agglutination  and are unsuitable  for phagocytic tests. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 110  PLATE  40 
FIG.  1 
(Foley and Wood: Pathogenicity of Group A streptococci, lI) 